Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment

Authors:

Abstract
Rheumatology key messageAnakinra as a sole treatment may be useful in the immune-mediated hyperinflammatory phase of COVID-19.

This publication has 10 references indexed in Scilit: